<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04187196</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00061732</org_study_id>
    <nct_id>NCT04187196</nct_id>
  </id_info>
  <brief_title>Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion</brief_title>
  <official_title>Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, open-blinded, prospective study to evaluate the timeliness and safety of direct
      current cardioversion (DCCV) when using methohexital when compared to the more often used
      propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators theorize that the use of methohexital during cardioversion will result in a
      shorter time to effective sedation and time to full recovery when compared to the use of
      propofol. This will change how sedation is approached for elective cardioversions.

      Primary Hypothesis:

        1. The mean time to recovery from sedation during a cardioversion using methohexital for
           sedation will be significantly shorter than the recovery time using propofol for
           sedation, as evidenced by a short time from initiation of induction to a score of 2 on
           the Ramsay Sedation Scale.

        2. The mean time to a Ramsay score of 5-6 will be significantly shorter using methohexital
           than the time to the same sedation level using propofol

      Secondary Hypothesis:

      1. There will be no significant increase in adverse events associated with the use of
      methohexital when compared with propofol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2020</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from initiation of sedation to full recovery</measure>
    <time_frame>Day 1</time_frame>
    <description>The time from initiation of sedation to full recovery (RSS of 2) as evidenced by the ability to answer the questions &quot;What is your name and what is your age?&quot; We will start the timer at the initiation of induction.Recorded in seconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from end of injection to loss of conscious</measure>
    <time_frame>Day 1</time_frame>
    <description>Recorded in seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first shock</measure>
    <time_frame>Day 1</time_frame>
    <description>Recorded in seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to eyes opening</measure>
    <time_frame>Day 1</time_frame>
    <description>Recorded in seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1, at induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1, prior to first shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Day 1,30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1, at induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1, prior to first shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1,15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1, 20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Day 1, 30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, at induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, prior to fist shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial Blood Pressure</measure>
    <time_frame>Day 1, 30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, prior to first shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1,1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Rate</measure>
    <time_frame>Day 1, 30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, at induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, prior to first shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Day 1, 30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, at induction</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, prior to first shock</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1,1 minute after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 3 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 5 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 7 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 9 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 10 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 15 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Day 1, 20 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>30 minutes after first cardioversion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recall of pain at injection site - visual analog scale</measure>
    <time_frame>Day 1</time_frame>
    <description>These are 100 mm lines that are anchored with &quot;no pain&quot; on one end and &quot;worst imaginable pain&quot; on the other end. Total range 0-100, higher numbers correspond to worse pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recall of anything unpleasant about the procedure - visual analog scale</measure>
    <time_frame>Day 1</time_frame>
    <description>These are 100 mm lines that are anchored with &quot;no distress&quot; on one end and &quot;worst imaginable distress&quot; on the other end. Total range 0-100, higher numbers correspond to worse distress.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Atrial Flutter</condition>
  <arm_group>
    <arm_group_label>Sedation with propofol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will be randomized to sedation with bolus dosing of propofol for cardioversion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedation with methohexital group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will be randomized to sedation with bolus dosing of methohexital for cardioversion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol will be given at an initial dose of 0.8 mg/kg followed by 20 mg every minute after 2 minutes, if adequate sedation is not achieved</description>
    <arm_group_label>Sedation with propofol group</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methohexital</intervention_name>
    <description>Methohexital will be given at an initial dose of 0.5 mg/kg, followed by 10 mg every minute after 2 minutes, if adequate sedation is not achieved</description>
    <arm_group_label>Sedation with methohexital group</arm_group_label>
    <other_name>Brevital</other_name>
    <other_name>Brietal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who present to Wake Forest Baptist Medical Center for a direct current
             cardioversion for treatment of paroxysmal or persistent atrial fibrillation as well as
             atrial flutter.

        Exclusion Criteria:

          -  Patients with sedation for transesophageal echocardiogram within 30 minutes of DCCV

          -  Hemodynamically compromised patients (as defined by hypotension &lt;90/50 mmHg, altered
             mental status, shock, ischemic chest discomfort, or heart failure)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elijah Beaty, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen Blinson</last_name>
    <phone>336.716.5706</phone>
    <email>kblinson@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 26, 2019</study_first_submitted>
  <study_first_submitted_qc>December 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2019</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardioversion</keyword>
  <keyword>Propofol</keyword>
  <keyword>Deep sedation</keyword>
  <keyword>Intravenous anesthetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Atrial Flutter</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Methohexital</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

